AR026022A1 - Metodo para el tratamiento de la obesidad - Google Patents
Metodo para el tratamiento de la obesidadInfo
- Publication number
- AR026022A1 AR026022A1 ARP000105369A ARP000105369A AR026022A1 AR 026022 A1 AR026022 A1 AR 026022A1 AR P000105369 A ARP000105369 A AR P000105369A AR P000105369 A ARP000105369 A AR P000105369A AR 026022 A1 AR026022 A1 AR 026022A1
- Authority
- AR
- Argentina
- Prior art keywords
- obesity
- treatment
- solvatofarma
- animal
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Método para el tratamiento de la obesidad que comprende administrar a un animal que necesite del mismo, un compuesto de formula (1) o una sal o solvatofarmacéuticamente aceptable del mismo. Los métodos para la supresion del apetito, para causarpérdi da de peso, para prevenir el aumento de peso, para afectarpreferencialmente la composicion grasa del cuerpo, para inhibir el antojo del alimento, o para mantener el peso bajo también se describen.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9924275.2A GB9924275D0 (en) | 1999-10-13 | 1999-10-13 | Method for the treatment of obesity |
| GB0001861A GB0001861D0 (en) | 2000-01-28 | 2000-01-28 | Method for the treatment of obesity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR026022A1 true AR026022A1 (es) | 2002-12-26 |
Family
ID=26243494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000105369A AR026022A1 (es) | 1999-10-13 | 2000-10-12 | Metodo para el tratamiento de la obesidad |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1220673A2 (es) |
| JP (1) | JP2003511410A (es) |
| AR (1) | AR026022A1 (es) |
| AU (1) | AU7750100A (es) |
| PE (1) | PE20010744A1 (es) |
| WO (1) | WO2001026641A2 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04001165A (es) | 2001-08-08 | 2004-05-20 | R Orton Kevin | Aparato y metodo para una reduccion de peso electricamente conductiva. |
| MXPA04011203A (es) | 2002-05-17 | 2005-07-14 | Univ Duke | Metodo para tratar la obesidad. |
| EP2316456B1 (en) | 2003-04-29 | 2017-06-14 | Orexigen Therapeutics, Inc. | Compositions for affecting weight loss comprising an opioid antagonist and bupropion |
| WO2007067341A2 (en) | 2005-11-22 | 2007-06-14 | Orexigen Therapeutics, Inc. | Compositions and methods for increasing insulin sensitivity |
| US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
| MX343867B (es) | 2006-11-09 | 2016-11-25 | Orexigen Therapeutics Inc | Paquete de dosificacion unitaria y metodos para administrar medicaciones de perdida de peso. |
| CA2715527A1 (en) * | 2007-12-05 | 2009-06-11 | Michael Higginbottom | New compounds iv |
| CA2725930A1 (en) | 2008-05-30 | 2009-12-30 | Orexigen Therapeutics, Inc. | Methods for treating visceral fat conditions |
| MX2010013353A (es) * | 2008-06-04 | 2010-12-21 | Astrazeneca Ab | Nuevos compuestos vii. |
| US9248123B2 (en) | 2010-01-11 | 2016-02-02 | Orexigen Therapeutics, Inc. | Methods of providing weight loss therapy in patients with major depression |
| AU2013271622B2 (en) | 2012-06-06 | 2018-03-01 | Nalpropion Pharmaceuticals Llc | Methods of treating overweight and obesity |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8924528D0 (en) * | 1989-10-31 | 1989-12-20 | Wellcome Found | Heterocyclic pharmaceutical compounds,preparation and use |
| AU744261B2 (en) * | 1997-04-24 | 2002-02-21 | Merck Sharp & Dohme Limited | Use of NK-1 receptor antagonists for treating eating disorders |
| WO1999025355A1 (en) * | 1997-11-14 | 1999-05-27 | Glaxo Group Ltd. | Method of treating addiction to nicotine products |
| EP1829544A1 (en) * | 1998-01-21 | 2007-09-05 | Glaxo Group Limited | Pharmaceutically active morpholinol |
| MA26693A1 (fr) * | 1998-09-28 | 2004-12-20 | Glaxo Group Ltd | Compositions pour administration par voie buccale |
-
2000
- 2000-10-03 AU AU77501/00A patent/AU7750100A/en not_active Abandoned
- 2000-10-03 EP EP00967281A patent/EP1220673A2/en not_active Withdrawn
- 2000-10-03 WO PCT/US2000/027252 patent/WO2001026641A2/en not_active Application Discontinuation
- 2000-10-03 JP JP2001529431A patent/JP2003511410A/ja active Pending
- 2000-10-11 PE PE2000001089A patent/PE20010744A1/es not_active Application Discontinuation
- 2000-10-12 AR ARP000105369A patent/AR026022A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001026641A2 (en) | 2001-04-19 |
| PE20010744A1 (es) | 2001-07-23 |
| WO2001026641A3 (en) | 2002-01-10 |
| JP2003511410A (ja) | 2003-03-25 |
| AU7750100A (en) | 2001-04-23 |
| EP1220673A2 (en) | 2002-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR030933A1 (es) | Derivados del triazol y composiciones farmaceuticas que los contienen | |
| CO6331425A2 (es) | Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida | |
| DOP2004001052A (es) | Inhibidores heterociclil amino de 11-beta-hidroxiesteroide deshidrogenasa tipo 1 | |
| CY1106634T1 (el) | Θεραπευτικα παραγωγα της πιπεραζινης | |
| CO5251429A1 (es) | Derivados de ter-butil-(7-metil-imidazo(1,2-a)piridin-3- il)-amina procedimiento para su preparacion, medicamentos que los contienen, su uso para la preparacion de un medicamento para la inhibicion de la no-sintasa y composiciones farmaceuticas que l | |
| PA8591701A1 (es) | Derivados de pirrolopirimidina | |
| CY1109242T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου | |
| AR026022A1 (es) | Metodo para el tratamiento de la obesidad | |
| UY29085A1 (es) | Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes | |
| UY26635A1 (es) | Métodos sinérgicos y composiciones para el tratamiento del cáncer | |
| TR200102646T2 (tr) | Yeme bozukluklarının tedavi edilmesi. | |
| ES2295609T3 (es) | Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor. | |
| BR0314943A (pt) | Inibidores da proteìna reguladora da condutância transmembrana da fibrose cìstica e usos destes | |
| WO2005030766A8 (en) | Phenyl - carboxamide compounds useful for treating pain | |
| AR039190A1 (es) | Derivados de benzofurano, composicion farmaceutica y medicamento que comprende el compuesto | |
| RU2019121690A (ru) | Дексмедетомидин или медетомидин для применения для лечения сепарационной тревожности у собак | |
| AR014964A1 (es) | Derivados de indol, composiciones farmaceuticas que los contienen, agentes para reducir la presion intraocular, tratar glaucoma e hipertension ocular, usosen la fabricacion de composiciones farmaceuticas y procedimiento de fabricacion de dichas composiciones | |
| CL2023000196A1 (es) | Compuestos de tetrahidropirazolo-pirazinil-dihidroimidazolona o tetrahidropirazolo-piridinil-dihidroimidazolona y métodos de uso de los mismos | |
| AU2002357191A1 (en) | Derivatives of isoindigo, indigo and indirubin and use in treating cancer | |
| BR0305708A (pt) | Derivados de benzimidazol para o tratamento de disfunção sexual | |
| ATE366107T1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| EA200601249A1 (ru) | Пиперазины, пригодные для лечения боли | |
| AR050358A1 (es) | Composiciones capaces de inhibir especies reactivas de oxigeno y carbonilo | |
| NO912414L (no) | Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling. | |
| DE60123117D1 (de) | Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs |